1-3 of 3 results for subject:Pfizer
Librarians' tools
- Search time
- 0.184 seconds
- Solr query time
- 0.002 seconds
- Search query
- subject:Pfizer
- We searched for
- subject_t:Pfizer OR subject_ses:61578
Type
House
Session
Year
Department
Member
Primary member
More
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Health and Social Care, how many additional cold chain storage refrigerators capable of safely storing the Pfizer-BioNTech vaccine have been (a) ordered, (b) delivered and (c) deployed by the Government in each month since 1 September 2020.
To ask the Secretary of State for Health and Social Care, how many additional cold chain storage refrigerators capable of safely storing the Pfizer-BioNTech vaccine have been (a) ordered, (b) delivered and (c) deployed by the Government in each month since 1 September 2020.
Public Health England (PHE) secured 58 ultra-low temperature (ULT) freezers which provide sufficient storage for approximately five million doses of potential COVID-19 vaccines which require ULT storage. These ULT freezers were in place, commissioned and ready to receive vaccine prior to the commencement of the programme at the beginning of December 2020. The ULT freezers are for PHE to manage the national storage of COVID-19 vaccines which require storage at -70°C. The National Health Service has secured its own ULT freezers to support local storage.
PQ141991
To ask the Secretary of State for Business, Energy and Industrial Strategy, how many doses of the (a) Pfizer-BioNTech and (b) Oxford-AstraZeneca vaccine are physically present in the UK and being held in storage, yet to be deployed or prepared for delivery.
To ask the Secretary of State for Business, Energy and Industrial Strategy, how many doses of the (a) Pfizer-BioNTech and (b) Oxford-AstraZeneca vaccine are physically present in the UK and being held in storage, yet to be deployed or prepared for delivery.
The Government has procured 40 million doses of the Pfizer/BioNTech and 100 million doses of the Oxford University/AstraZeneca vaccines.
The UK was the first country in the world to start a vaccination programme using these vaccines. As of 26 January 2021, over 6.85 million people across the UK have been vaccinated with the first dose of the vaccine. We continue to work to meet our target of vaccinating all four priority groups by 15 February.
Vaccines are a precious resource in very high demand across the world; therefore, for security reasons it is not possible to provide detail about the size of our supplies and exact detail about deliveries.
To ask the Secretary of State for Business, Energy and Industrial Strategy, whether the decision by Pfizer to make changes to manufacturing processes of its covid-19 vaccine to boost production will affect the distribution of that vaccine to the UK from late January to early February 2021.
To ask the Secretary of State for Business, Energy and Industrial Strategy, whether the decision by Pfizer to make changes to manufacturing processes of its covid-19 vaccine to boost production will affect the distribution of that vaccine to the UK from late January to early February 2021.
Vaccines are a precious resource and are in very high demand across the world; therefore, for security reasons it is not possible to provide detail about the size of our supplies or give exact detail about future deliveries.
We have been monitoring the requirements across the supply chain from supplier through to patients for some time. All vaccine candidates’ supply and onward deployment have clear supply chain plans across the value chain, including materials, manufacturing, transportation, storage, and distribution.
As of 18 January 2021, over 4.6 million people in the UK had been vaccinated with the first dose of the vaccine. We are in the process of understanding the implications of Pfizer’s announcement on 15 January regarding upgrades to its manufacturing capacity. We continue to work to meet our target of vaccinating all four priority groups, as advised by the Joint Committee on Vaccination and Immunisation, by the middle of February.